Read on Twitter
Very excited to be listening to Odd Lots live at #EconTwitterIRL 
Like the discussion of competing on science vs execution vs China. US can compete on advanced science but less so on manufacturing at low cost. China executes best where science is mature. Clean tech is an important case where US is still playing catch-up
#EconTwitterIRL
#EconTwitterIRL
And Dan Wang's impression is that China regards AI similarly to social media where it's a technology to control rather than an opportunity for productivity growth. Evidently Twitter doesn't improve productivity
#EconTwitterIRL
#EconTwitterIRL
On tit-for-tat industrial policy:
Adam argues that as long as we're competing by getting costs down rather than artificially raising costs, we can still win in the LR.
Dan points out it's hard to out-spend the US
Adam argues that as long as we're competing by getting costs down rather than artificially raising costs, we can still win in the LR.
Dan points out it's hard to out-spend the US
From Heidi Williams: Shortening the timeframe for clinical trials (e.g., testing vaccine for impact on HPV rather than cervical cancer) means you can start capturing the benefits for patients faster.
Parallel to how tech thinks about A/B testing program design.
#EconTwitterIRL
Parallel to how tech thinks about A/B testing program design.
#EconTwitterIRL
And from Eli Dourado: If we think about science as an industry, it's not unreasonable to see it as dysfunctional in the same way we talk about housing, healthcare, etc. More R&D $ is good & all but just pouring $ in isn't a solution itself to improving processes
#EconTwitterIRL
#EconTwitterIRL
• • •
Missing some Tweet in this thread? You can try to
force a refresh
